In December, the U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced his office would begin rolling out the $50 billion Rural Health Transformation Program funding. But rural health advocates are divided on what it will mean for rural communities.
In his confirmation hearings, Robert F. Kennedy Jr. told U.S. senators that he would not cut funding for vaccine research or change the nation's official vaccine recommendations. He did both.
The Administration for a Healthy America is RFK Jr.'s plan to tackle chronic disease, addiction and other persistent problems. But so far it's not being set up like previous new agencies.
A federal vaccine advisory committee has voted to end a longstanding recommendation that all U.S. babies get the hepatitis B vaccine on the day they’re born.
They're framing it as a way to share data and messages about threats, emergency preparedness and public health policy at a time when the federal government isn't doing its job in public health.
Two groups are calling for new leadership at HHS after Health Secretary Robert F. Kennedy Jr.'s actions on substance abuse treatment and mental health medications, among other issues.
Both U.S. senators from Georgia called for the firing of Robert F. Kennedy Jr., Thursday, after weeks of chaos at CDC headquarters in Atlanta and a shooting that killed a DeKalb County police officer.
Americans get about 55% of our calories from tasty, cheap — and unhealthy — manufactured foods, the latest data from CDC says. For kids, the percentage is even higher.
The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like COVID-19 and the flu.
AAP and other leading health organizations allege that the health secretary violated federal law when he took the COVID vaccine off the list of recommended shots for pregnant women and healthy children.
When RFK Jr. announced he would cut funds from Gavi, the Vaccine Alliance, he cited "vaccine safety," referring to a 2017 study from Guinea-Bissau. We asked vaccine researchers to assess the study.